Future

medicine

3 Psychedelic Stocks to Invest In the Future of Medicine

InvestorPlace – Stock Market News, Stock Advice & Trading Tips

Psychedelic drugs are going mainstream fast, with research supporting their effectiveness in alleviating emotional problems. Scientists continue to revisit different psychedelics such as LSD, magic mushrooms and other therapeutics for a range of mental ailments. Research is in full swing with the announcement from Johns Hopkins on its development of the Center for Psychedelic and Consciousness Research. With a $17 million commitment for planned studies, the research will further help in normalizing psychedelics. Therefore, the shroom boom has well and truly arrived, and investors should seriously consider adding psychedelic stocks to their portfolios.

Investor interest in psychedelics is on the rise as high-profile executives and celebrities are investing in the sector’s future. With such much interest in alternative psychedelic medicine, analysts believe that the sector could bring in over $6.85 billion by 2027. However, government support and widespread legalization are essential for its rapid advancement. With the recent legalization of psychedelics in various states, it won’t be long when they line up pharmacy aisles.

It is imperative to invest in psychedelic stocks that are needle-movers having the most potential for sustained success. Here are three that stand out right now:

  • Champignon Brands (OTCMKTS:SHRMF)
  • Mind Medicine (OTCMKTS:MMEDF)
  • Hollister Biosciences (OTCMKTS:HSTRF)

Psychedelic Stocks to Buy: Champignon Brands (SHRMF)

Source: local_doctor / Shutterstock.com

Champignon Brands is among the first movers in the psychedelic medicine field and it completed its IPO earlier this year. It is engaged in the production of novel medications, specifically medicinal mushroom products, which aim to treat a variety of mental health problems. It boasts one of the strongest research teams led by its Special Advisory Committee, working diligently to provide high-quality data to its production team. Hence, SHRMF stock is among the hottest investments in the burgeoning psychedelics field.

It has been a busy 2020 for the Vancouver-based company. In April, it announced that it would be acquiring clinic operator AltMed Capital Corp, aiming at opening several subspecialty therapeutic clinics across the U.S. Additionally, the deal also provides several intellectual properties in developing novel medicines. Moreover, Champignon is also looking to open clinics for psychedelics, such as ketamine, psilocybin and MDMA throughout the North American continent.

It has six current trials in Phase I and pre-clinical stages collectively and seven patents pursuing ketamine/psilocybin solutions. To better reflect its scientific alignments, it is proposing a name change to Apotheosis Scientific Ltd. Therefore, with so much on its plate, the company can become a juggernaut among psychedelic stocks.

Mind Medicine (MMEDF)

Business psychology concept and wealth thinking

Source: Shutterstock

MindMedicine is one of the largest biotechs involved in psychedelic drugs’ clinical development tackling mental health troubles. With the success of its Compass Pathways IPO, it is now looking to enlist on the U.S. stock exchange. It would become the second pure-play to be listed on Nasdaq. Hence, MMEDF stock is one of the top investments in the sector with massive potential.

It has three on-going clinical trials, which can be major

Read More
medicine

The New Coronavirus Vaccine Is Changing The Future Of Medicine

While the vaccines for Covid-19 seem to have been created in record time, the technology making them possible has been decades in development. The two vaccine candidates produced by Pfizer/BioNTech and Moderna are unlike any other vaccine that’s come before. Should they achieve commercial success, it could usher in a new era of medical science — not just for vaccines, but for cancer treatments, blood disorders, and gene therapy.

The two new vaccines are the first ever to use mRNA, which stands for “messenger RNA,” to generate immunity. Historically, vaccines have used dead or weakened viruses to imitate an infection, spurring the body to make antibodies against that virus without danger of getting sick. Measles, polio, and some seasonal flu shots are examples of vaccines made with whole virus particles.

Other vaccines use only certain fragments of the virus, called antigens, that provoke an immune response. To make this type of vaccine, the genetic code for the desired viral antigen molecule is put into yeast or bacteria cells. These microbes can be grown rapidly and inexpensively, and they can churn out massive quantities of antigen. Then the molecule must be purified to clinical standards so that it’s safe to inject into healthy people. Prevnar and Gardasil are examples of this type of vaccine.

These methods work well, but they require enormous research and development efforts. A laboratory could spend years optimizing the methods for producing one virus protein, but those methods wouldn’t automatically translate to mass-producing a different protein.

“For every new protein, you start over. It’s a brand-new procedure every step of the way,” explains immunologist Drew Weissman of the Perelman School of Medicine at the University of Pennsylvania. Weissman is one of the pioneering scientists behind the mRNA vaccine.

“The way I see it, the mRNA platform is much better, it’s much quicker, and it’s cheaper,” says Weissman. “That’s the trilogy of what you need to improve vaccines.” With mRNA, the steps are the same, no matter what virus the vaccine is targeting. This makes it easily customizable. Once an mRNA manufacturing facility is up and running, it can easily be deployed to make vaccines against any number of viral antigens.

How is that possible? Here’s how it works

A strand of mRNA carries the instructions for making one protein. Your cells normally make their own mRNA strands and use them as blueprints to manufacture all the proteins your body needs to function.

The vaccine slips a new strand of mRNA into the cell, like an extra page in the blueprint. This mRNA contains the instructions for making the coronavirus spike protein, and the cell reads it the same way it reads its own mRNAs, using it to build the viral protein. The immune system recognizes that protein as foreign, and starts making antibodies against it. Then, if you’re exposed

Read More
medicine

Sports Medicine Market Analysis by Applications, End-Users, Top Companies, Future Growth Opportunities, Product Type, Global Forecast To 2020

The MarketWatch News Department was not involved in the creation of this content.

Japan, Japan, Wed, 02 Dec 2020 14:20:31 / Comserve Inc. / — Over the years, the sports medicine market has witnessed various technological advancements made to ensure and provide better recovery and rehabilitative measures for injuries caused during sports or physical activities.

The sports medicine market comprises products and devices used by professional or non-professional athletes or sportspersons to prevent and protect themselves from injuries as well as devices that enhance performance. The sports medicine products play an important role in the rehabilitation, recovery, protection, endurance, and monitoring of athletes while playing sports. Over the years, the sports medicine market has witnessed various technological advancements made to ensure and provide better recovery and rehabilitative measures for injuries caused during sports or physical activities.

These advancements have led to the development of new products and therapies to treat sports injuries. Various market players are focusing on the introduction of newer products and treatment options for sports injuries. A number of key players are competing to secure larger shares of the market by launching new products. Arthrex, Inc. (U.S.), Smith & Nephew PLC (U.K.), DePuy Synthes Companies (U.S.), Stryker Corporation (U.S.), and CONMED Corporation (U.S.) are the top five players of this market

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-61031

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

In 2015, the body reconstruction & repair products segment is expected to account for the largest share of the global sports medicine market, by product, while the knee injuries segment is expected to account for the largest share of the sports medicine market, by application.

In 2015, North America is expected to account for the largest share of the global sports medicine market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). In the coming years, the sports medicine market is expected to witness the highest growth rate in the Asia-Pacific region, with emphasis on India, China, and Japan. The entry of international players, increasing government initiatives, and rising awareness regarding sports medicine in emerging nations like India and China are expected to drive the market in these regions.

The sports medicine market witnesses high competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various growth strategies (agreements, partnerships, joint ventures, geographic expansions, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global market.

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market

Read More
fitness

Why TikTok might be the future of online fitness

There is a strange paradox within the home workout boom: 2020 has absolutely necessitated them, a way of keeping fit with an expert eye overseeing you at a time when fitness offerings were few and far between. But the curse is that social media, where most of these workouts can be found, is also a place where people promote a certain kind of flawlessness: an aptitude and exceptionalism in their physique that doesn’t always translate well to someone who, furloughed and in need of an outlet, wants to start doing HIIT for the first time. 

While Instagram remains a vital resource if you’re looking for free workouts from some of the industry’s greats, there’s a new social media outlet that’s offering something a little bit different: TikTok. Famed for its viral trends, dance routines and Vine-like chaos, TikTok is not without controversy. But it has carved out a particularly interesting niche for fitness professionals: a space where people can be athletic and hot, but also have a personality. 

TikTok might not seem like the next place to look to for help with your workouts – its videos are short, its energy much more scrappy – but the people who are making names for themselves on the app have found that it’s the perfect place to suggest new workouts, trial unusual supersets and even just go over the basics of gym etiquette and exercise form for people who need a refresher. Whether you’re an exercise newbie or a veteran, it might be worth turning your attention to TikTok.

Two things lead the men of Fitness TikTok to the platform: young girls in their families and seeing an opportunity to grow an audience. For Eyal Booker, it was seeing his younger sister using it; for Paul Olima, it was his daughter. For Alex Crockford and Franklin Sopuluchukwu, it was a chance to build an audience and give their expertise to a new group of people who needed it. 

David Templer, a 30-year-old personal trainer and content curator, first joined TikTok as part of a paid partnership. “I think TikTok reached out to me and offered me £150 to set up an account,” he explained. “And then I also just post a few bits of content both on my TikTok channel and my Instagram feeds. I got addicted within a week.”

Templer’s entire business model is built on a holistic approach to health: nutrition and fitness go hand in hand, and he’s found a huge amount of success with his “shirtless chef” recipe videos, his often audaciously OTT meals finding a huge audience during lockdown. But fitness still continues to drive a lot of traffic for him: one of his most successful videos, at the time of talking, had been a guide on how to do a deadlift. “I think it is those educational pieces that people are really, really looking for, so I think what I’m going to do is go back into doing those one-off tutorials.”

For Templer, the real power

Read More
medicine

Remdesivir Medicine Market Will Hit Big Revenues In Future | Sanofi, Gilead Sciences, GlaxoSmithKline – Press Release

Remdesivir Medicine Market Will Hit Big Revenues In Future | Sanofi, Gilead Sciences, GlaxoSmithKline

Remdesivir Medicine Comprehensive Study by Application (Ebola Virus Disease, Marburg Virus Infection, Possible COVID-19 Treatment), Administration (Oral, Intravenous), End-users (Hospitals, Clinics, Ambulatory Surgical Centers, Others), Distribution Channel (Online Channel, Offline Channel) Players and Region – Global Market Outlook to 2025.

Global Remdesivir Medicine Market Comprehensive Study is an expert and top to bottom investigation on the momentum condition of the worldwide Global Remdesivir Medicine industry with an attention on the Global market. The report gives key insights available status of the Global Remdesivir Medicine producers and is an important wellspring of direction and course for organizations and people keen on the business. By and large, the report gives an inside and out understanding of 2020-2025 worldwide Remdesivir Medicine Market covering extremely significant parameters.

Key Players in This Report Include,
Gilead Sciences, Inc. (United States), Hainan Haiyao Co., Ltd. (China), Sanofi S.A. (France), GlaxoSmithKline plc (United Kingdom) and Cipla (India)

Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/128698-global-remdesivir-medicine-market

Brief Summary of Global Remdesivir Medicine:
Remdesivir medicine is an anti-viral medication being studied as a possible post-infection treatment for COVID-19 illness. This medicine is a nucleotide analog, specifically an adenosine analog, which inserts into viral RNA chains causing their premature termination. It was developed by Gilead Sciences as a treatment for Ebola virus disease and Marburg virus infections. It is an investigational antiviral compound undergoing clinical trials in China, the United States and the United Kingdom as a potential treatment for COVID-19. It is not yet licensed or approved anywhere globally and has not been demonstrated to be safe or effective for any use.

Market Drivers

  • Increased Prevalence of COVID-19 Illness
  • Highly Effective Anti-viral Medicine

 

Market Trend

  • High Demand for Coronavirus Disease Treatment

 

Restraints

  • Lack of Clinical Evidence for COVID-19 Treatment

 

Opportunities

  • Increasing Number of Patients affecting COVID-19
  • Growth in the Healthcare Industry

 

Challenges

  • Stringent Government Rules and Regulations

This research report represents a 360-degree overview of the competitive landscape of the Global Remdesivir Medicine Market. Furthermore, it offers massive data relating to recent trends, technological, advancements, tools, and methodologies. The research report analyzes the Global Remdesivir Medicine Market in a detailed and concise manner for better insights into the businesses.

Regions Covered in the Global Remdesivir Medicine Market:

  • The Middle East and Africa (South Africa, Saudi Arabia, UAE, Israel, Egypt, etc.)
  • North America (United States, Mexico & Canada)
  • South America (Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, etc.)
  • Europe (Turkey, Spain, Turkey, Netherlands Denmark, Belgium, Switzerland, Germany, Russia UK, Italy, France, etc.)
  • Asia-Pacific (Taiwan, Hong Kong, Singapore, Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia).


Enquire for customization in Report @ https://www.advancemarketanalytics.com/enquiry-before-buy/128698-global-remdesivir-medicine-market

The research study has taken the help of graphical presentation techniques such as infographics, charts, tables, and pictures. It provides guidelines for both established players and new entrants in the Global Remdesivir Medicine Market.

The detailed elaboration of the Global Remdesivir Medicine Market has been provided by applying industry analysis techniques such

Read More
fitness

The Trends Shaping the Future of the Personal Fitness Training Industry

Traditionally, if you wanted to get fit, you would sign up for a gym and go there regularly to lift weights, use the treadmill or perform other exercises. Alternatively, you could focus on cardio and take up running, cycling, or other sports. In either case, you could get a personal trainer to provide guidance and help you achieve your goals. 



a man sitting at a table using a laptop


© filadendron | Getty Images


The events of this year have changed those options drastically, however. As a result of the restriction on movements around the world, outdoor sports have not been an option for a few months, and nor have going to the gym or meeting with your personal trainer. Those happenings have all culminated in a defining moment for the fitness industry, shaking the traditional models up and presenting a plethora of opportunities for entrepreneurs willing to exercise their business muscles.

Loading...

Load Error

Related: Tips to Get into the Booming Health and Fitness Industry

Streaming Services

The global online fitness market size was estimated to have a value of  6,046 Million dollars in 2019 many studies have projected that it will likely attain a size of 59,231 Million dollars in 2027. That would represent growth of about 33.1% annually each year. This growth is largely driven by a variety of products and services that have sprung up to revolutionize the fitness industry by making it safer and more convenient to access fitness training through on-demand classes and workouts taught by experienced fitness trainers. These are typically accessible using apps that can be downloaded onto mobile phones, computers, and TVs. The personal trainer experience is diluted to an extent in this model because the classes and workouts are not personal in that they are produced like any other video and then published for the access of all subscribers to the service.

Nonetheless, personal trainers are able to still provide effective direction and motivation for most people to have a complete and satisfying workout. In addition, the prices for the streaming services are generally very affordable, with many of them being in the $20 range, thus making removing cost as a barrier for most people. 

Related: This Business Owner Helps Fitness Trainers Go From Hourly Wages …

Virtual Coaching Classes

For those who find the pre-recorded workouts too impersonal, the next step up is to find a personal trainer who offers virtual coaching classes. These classes are held using tools like Zoom and Google Meet which though not originally intended for use by personal trainers, lend themselves well to the purpose. With those tools, trainers can cater to groups of students in live sessions and offer a more personal and interactive session that can be obtained using the streaming services.

Many startups have launched to facilitate these classes, connecting students to personal trainers. Even with the fees that these companies charge for their services, personal trainers are still able to earn sums of money that far outstrip the average personal trainer salary. Most of the services allow the personal trainers

Read More
medicine

RESILIENCE Launches to Change the Future of Medicine through Manufacturing Innovation

SAN DIEGO and BOSTON, Nov. 23, 2020 /PRNewswire/ — RESILIENCE (National Resilience, Inc.), a new company building the world’s most advanced biopharmaceutical manufacturing ecosystem, announced its launch today. 

The company will actively invest in developing powerful new technologies to manufacture complex medicines that are defining the future of therapeutics, including cell and gene therapies, viral vectors, vaccines, and proteins. In doing so, it seeks to overcome one of the biggest challenges the biopharmaceutical industry is facing in pioneering novel treatment modalities – manufacturing. RESILIENCE will dramatically increase overall production capacity for these modalities, ensuring that important medicines are accessible to all patients in need and protecting against supply chain disruption.

“We created RESILIENCE to reimagine biopharmaceutical manufacturing through unprecedented investment in technology and a best-in-class team to execute our vision,” said Robert Nelsen, RESILIENCE founder, Chairman of the Board, and managing director at ARCH Venture Partners. “COVID-19 has exposed critical vulnerabilities in medical supply chains, and today’s manufacturing can’t keep up with scientific innovation, medical discovery, and the need to rapidly produce and distribute critically important drugs at scale. We are committed to tackling these huge problems with a whole new business model.”

Company Focus

RESILIENCE seeks to address today’s challenges while investing in the future of U.S.-led biopharmaceutical innovation. RESILIENCE will offer customized and scalable processes, short lead times, the highest quality and regulatory capabilities, and world-class manufacturing facilities. It will serve partners of all sizes, including pharmaceutical and biotechnology companies, universities, independent research organizations, and government programs. By enabling complex medicine manufacturing that is faster, more flexible, and less risky, RESILIENCE empowers partners to focus on generating discoveries that improve medical outcomes and save patients’ lives.

“Our aim with RESILIENCE is to improve manufacturing of breakthrough medicines so that they are more accessible to patients and to foster scientific innovation that makes new modalities of medicine possible,” said RESILIENCE Co-Founder and CEO Rahul Singhvi, Sc.D. “By providing improved process platforms and the highest quality manufacturing network, RESILIENCE has been designed to help society meet the challenges of tomorrow, whether that’s the next pandemic or high demand for a great new medicine. I am incredibly proud to lead a team of extraordinary professionals with deep and diverse talent to build a more resilient future.”

RESILIENCE has raised over $800 million of capital following the recent Series B raise of approximately $750 million, not tied to milestones, from investors that collectively manage over $5 trillion. Led by ARCH Venture Partners and 8VC with participation by GV and NEA, investors include public mutual funds, some of the largest U.S.-based pharmaceutical companies, foundations, family offices, and pension funds, among others.

“It is critical that we adopt solutions that will protect the manufacturing supply chain, and provide more certainty around drug development and the ability to scale up the manufacturing of safe, effective but also more complex products that science is making possible,” said Scott Gottlieb, M.D., former Commissioner of the Food and Drug Administration and member

Read More
fitness

Lampard has full faith in Kante after questions of Chelsea midfielder’s form, fitness and future

The Blues boss saw the World Cup winner put in another impressive performance against Newcastle, with the Frenchman thriving after shaking off knocks

Frank Lampard claims to have “so much faith” in N’Golo Kante after seeing the Chelsea midfielder face questions of his form, fitness and future.

The France international has two Premier League titles and a World Cup winners’ medal to his name, but has seen a move away from Stamford Bridge mooted.

Speculation was first sparked when Maurizio Sarri took to shifting the 29-year-old out of his favoured holding role.

Lampard has also used Kante in a more advanced position during his reign in west London, but has seen him shine of late in the berth that made him a household name.

Goal 50 Revealed: The best 50 players in the world

Another eye-catching showing sweeping up in front of the Blues’ back four was put in against Newcastle on Saturday, in a 2-0 win for Chelsea, with confidence restored to all concerned.

Lampard told reporters on the influence Kante can have when performing at the peak of his powers: “I know what you mean by quietly influential but he’s much more than that for us.

“Last year he missed 50 per cent of the games with injuries, he had a tough time for different reasons and we are working very hard on that to get him fit and fresh.

“Now we are managing his training and game time, but his levels of performances are really high.

“I keep saying every time I get asked about N’Golo that I have so much faith in him and the top midfield player that he is in world football.

“Not just breaking up and winning balls back, as we know that is a huge quality of his, but his passing and supporting in midfield and playing in that deeper role now has been a very comfortable transition for him. Really, really happy with him.”

Lampard added when asked if he considers Kante to be over the injury issues that have been holding him back: “I don’t want to tempt fate as at the minute he is going well. It’s a constant one for us where we are managing it.

“When I came in at the start of last season he had been injured from the Europa League final and that just rolled on through the year so we just chased it down from there. That was unfortunate and so unfortunate for us to lose him for 50 per cent of the games because of the level of player he is.

“We have had a better period of him to get him in a place where we are really happy with.

“We’re aware and we keep check on his training and numbers and how much distance he travels because every time you train and allow him off the leash in training he makes ridiculous output because of the way he plays.

“We are very careful with that and at the

Read More
medicine

Artificial Intelligence in Precision Medicine Market Size Estimation, Industry Share, Future Demand, Dynamics, Drivers, Research Methodology by 2025

The MarketWatch News Department was not involved in the creation of this content.

Nov 19, 2020 (Market Insight Reports) —
Selbyville, Delaware Recently, Market Study Report, LLC, added a research on the ‘Artificial Intelligence (AI) in Precision Medicine market’ which encompasses significant inputs with respect to market share, market size, regional landscape, contributing players, and revenue projection of this industry vertical. The report also educates investors regarding the existing tends, prime challenges, and current expansion strategies applied by the key organizations that constitute the hyperactive competitive gamut of this business sphere.

Machine learning (ML), deep learning and artificial intelligence (AI) are gaining momentum in biomedicine. The primary goal is to recognize the future needs and trends and identify the requirements of AI and ML in precision health. According to Research report a??Global Artificial Intelligence (AI) in Precision Medicine Market Analysis, 2020a??, the Global AI in Precision Medicine market is anticipated to grow at a CAGR of around 50% during 2020-25. Machine learning algorithms are used in healthcare institutions to draw a large amount of patient data using genomic sequences. In addition, Artificial intelligence helps the companies to catalyse the drug development process and diminish in costs.

Request Sample Copy of this report at: https://www.marketstudyreport.com/request-a-sample/2767169/?utm_source=Marketwatch.com&utm_medium=Ram

Global Artificial Intelligence (AI) in Precision Medicine Market Analysis, 2020 research report depicts a deep dive market analysis of statistics of Global Artificial Intelligence (AI) in Precision Medicine market which consists of regional and country-wise market size, forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end-users, applications, product type, technologies, competitive benchmarking, etc.

AI Used in Drug Discovery Escalating the Natural Language Segment

In 2019, the natural language segment captured the highest market share in 2019. The primary factor for the growth of the segment is the constant use of technology in applications such as drug discovery and clinical trial identification.

Software Segment Bagged the Highest Growth

Based on type, the software segment registered the highest growth in 2019 as compared to the hardware and service segments in 2019. The major factor for the growth of the software segment is due to the continuous innovation in software with the evolving requirement in medicine. Moreover, the hardware segment is anticipated to foster a propelled demand through 2025 as revealed by the Research report a??Global Artificial Intelligence (AI) in Precision Medicine Market Analysis, 2020a??.

Collaboration of Companies for Innovation in Precision Medicine

According to Researchthe key players with a considerable market share in the Global AI in the Precision Medicine market include BioXcel Corporation, Alphabet Inc., Berg Health, General Vision, IBM Corporation, Microsoft Corporation, Intel Corporation, Enlitic Inc., General Vision, Nvidia Corporation, etc. Government organizations are investing heavily in AI companies resulting in the escalation of the research work. Besides, the snowballing importance in the field of precision medicine is luring opportunities in cross-industry collaboration and an influx of venture capital investments.

With the rising number of companies of artificial intelligence, the usage of AI in precision medicine is augmenting. For

Read More
fitness

Top fitness influencer entrepreneurs on future of the fitness industry

  • While gyms struggle to recover from a $10 billion shift away from in-person workouts, a crop of online fitness stars are leading us into digital transformation through virtual training programs and personal brands.
  • Business Insider asked influencers-turned-entrepreneurs how they see the future of the fitness industry changing from the pandemic.
  • They told us success will continue to be driven by social media and building strong communities.
  • Some see fitness taking on a hybrid model of both digital and physical experiences.
  • Visit Business Insider’s homepage for more stories.

Nationwide shutdowns because of the pandemic transformed the fitness industry at warp speed, hitting gyms and studios especially hard in favor of at-home workouts. 

Meanwhile, a crop of online fitness stars are leading us into digital transformation through virtual training programs and personalized apps, turning their massive followings into supportive communities, health and wellness platforms, and personal brands. 

Business Insider asked four top influencers-turned-entrepreneurs in the fitness space, how they see the future of the industry changing because of the pandemic.

Most agree success will continue to be driven by social media and building strong communities. Some see fitness taking on a hybrid model of both digital and physical experiences.

Some responses have been edited and condensed for clarity.

Read more » INSTAGRAM WORKOUTS: How 15 top fitness entrepreneurs are converting thousands of followers into customers on social media

Source Article

Read More